4.7 Article

Multiple binding modes of isothiocyanates that inhibit macrophage migration inhibitory factor

期刊

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
卷 93, 期 -, 页码 501-510

出版社

ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.ejmech.2015.02.012

关键词

Macrophage migration inhibitory factor; MIF; Tautomerase activity; Isothiocyanate; Covalent

资金

  1. University of Otago Research Grant
  2. New Zealand Synchrotron Group
  3. University of Otago Doctoral Scholarship

向作者/读者索取更多资源

Macrophage migration inhibitory factor (MIF) is a pleiotropic cytokine that has roles in the innate immune response, and also contributes to inflammatory disease. While the biological properties of MIF are closely linked to protein protein interactions, MW also has tautomerase activity. Inhibition of this activity interferes with the interaction of MIF with protein partners e.g. the CD74 receptor, and tautomerase inhibitors show promise in disease models including multiple sclerosis and colitis. Isothiocyanates inhibit MIF tautomerase activity via covalent modification of the N-terminal proline. We systematically explored variants of benzyl and phenethyl isothiocyanates, to define determinants of inhibition. In particular, substitution with hydroxyl, chloro, fluoro and trifluoro moieties at the para and meta positions were evaluated. In assays on treated cells and recombinant protein, the IC50 varied from 250 nM to >100 mu M. X-ray crystal structures of selected complexes revealed that two binding modes are accessed by some compounds, perhaps owing to strain in short linkers between the isothiocyanate and aromatic ring. The variety of binding modes confirms the existence of two subsites for inhibitors and establishes a platform for the development of potent inhibitors of MIF that only need to target one of these subsites. (C) 2015 Elsevier Masson SAS. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Chemistry, Medicinal

Design, synthesis and biological evaluation of P2-modified proline analogues targeting the HtrA serine protease in Chlamydia

Jimin Hwang, Natalie Strange, Rami Mazraani, Matthew J. Phillips, Allan B. Gamble, Wilhelmina M. Huston, Joel D. A. Tyndall

Summary: A new series of CtHtrA inhibitors were developed by proline ring expansion and Cg-substitutions, which showed significantly improved antichlamydial activity in vitro.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Biochemistry & Molecular Biology

Circulating protein carbonyls are specifically elevated in critically ill patients with pneumonia relative to other sources of sepsis

Emma Spencer, Patrice Rosengrave, Jonathan Williman, Geoff Shaw, Anitra C. Carr

Summary: Protein carbonyls concentrations increased in critically ill patients with septic shock, and patients with pneumonia had significantly higher protein carbonyl concentrations compared to other sources of sepsis. Vitamin C intervention did not attenuate the increase in protein carbonyls.

FREE RADICAL BIOLOGY AND MEDICINE (2022)

Article Pharmacology & Pharmacy

Improving Antibacterial Activity of a HtrA Protease Inhibitor JO146 against Helicobacter pylori: A Novel Approach Using Microfluidics-Engineered PLGA Nanoparticles

Jimin Hwang, Sonya Mros, Allan B. Gamble, Joel D. A. Tyndall, Arlene McDowell

Summary: Nanoparticle drug delivery systems offer a promising approach to address limitations of antimicrobial drugs. Controlled engineering of nanoparticle size using microfluidic technology can significantly improve drug delivery optimization.

PHARMACEUTICS (2022)

Article Biochemistry & Molecular Biology

Vitamin C Status in People with Types 1 and 2 Diabetes Mellitus and Varying Degrees of Renal Dysfunction: Relationship to Body Weight

Anitra C. Carr, Emma Spencer, Helen Heenan, Helen Lunt, Monica Vollebregt, Timothy C. R. Prickett

Summary: This study found that body weight is a significant predictor of vitamin C status in patients with diabetes, suggesting that those with higher body weight may require more vitamin C than average.

ANTIOXIDANTS (2022)

Article Microbiology

Characterisation of Candida parapsilosis CYP51 as a Drug Target Using Saccharomyces cerevisiae as Host

Yasmeen N. Ruma, Mikhail V. Keniya, Joel D. A. Tyndall, Brian C. Monk

Summary: The study characterized the wild type C. parapsilosis CYP51 and its resistance-causing point mutation Y132F, revealing increased resistance to fluconazole and voriconazole with the Y132F mutation. The research provides insights into the susceptibility of recombinant CYP51 from C. parapsilosis to azole drugs, which may help advance structure-directed antifungal discovery.

JOURNAL OF FUNGI (2022)

Article Chemistry, Medicinal

Structure-activity relationships of N-terminal variants of peptidomimetic tissue transglutaminase inhibitors

Nicole M. R. McNeil, Eric W. J. Gates, Neda Firoozi, Nicholas J. Cundy, Jessica Leccese, Sarah Eisinga, Joel D. A. Tyndall, Gautam Adhikary, Richard L. Eckert, Jeffrey W. Keillor

Summary: The multifunctional protein tissue transglutaminase (TG2) plays a key role in protein crosslinking and intracellular G-protein functions, with implications in diseases and cancer stem cell survival. A recent study focused on developing covalent inhibitors to selectively target the enzyme active site of TG2, showing promising results in enhancing efficiency and affinity for TG2. Molecular modelling was used to understand the binding mode of the inhibitors, with the most efficient ones demonstrating isozyme selectivity, blocking GTP binding, and improved pharmacokinetic properties.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Neurosciences

Neutrophil-vascular interactions drive myeloperoxidase accumulation in the brain in Alzheimer's disease

Leon C. D. Smyth, Helen C. Murray, Madison Hill, Eve van Leeuwen, Blake Highet, Nicholas J. Magon, Mahyar Osanlouy, Sophie N. Mathiesen, Bruce Mockett, Malvindar K. Singh-Bains, Vanessa K. Morris, Andrew N. Clarkson, Maurice A. Curtis, Wickliffe C. Abraham, Stephanie M. Hughes, Richard L. M. Faull, Anthony J. Kettle, Mike Dragunow, Mark B. Hampton

Summary: This study found that neutrophil accumulation in Alzheimer's disease is associated with cognitive impairment. The oxidant-generating enzyme myeloperoxidase (MPO) expressed in neutrophils could be a potential therapeutic target for AD. Vascular changes may drive neutrophil adhesion and NETosis.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2022)

Article Biochemistry & Molecular Biology

Hypothiocyanous Acid Disrupts the Barrier Function of Brain Endothelial Cells

Eveline van Leeuwen, Mark B. Hampton, Leon C. D. Smyth

Summary: Inflammation is a common feature in neurological diseases. This study demonstrates that a compound called hypothiocyanous acid can damage brain endothelial cells and result in the loss of barrier function, which may be a mechanism involved in neutrophil transmigration and neuroinflammation.

ANTIOXIDANTS (2022)

Article Biochemistry & Molecular Biology

A newly identified flavoprotein disulfide reductase Har protects Streptococcus pneumoniae against hypothiocyanous acid

Heather L. Shearer, Paul E. Pace, James C. Paton, Mark B. Hampton, Nina Dickerhof

Summary: This study reports the discovery of a previously unknown flavoprotein disulfide reductase with HOSCN reductase activity in HOSCN-tolerant Streptococcus pneumoniae, and demonstrates the role of this protein in combination with GSH utilization in protecting the bacteria from HOSCN.

JOURNAL OF BIOLOGICAL CHEMISTRY (2022)

Article Gastroenterology & Hepatology

Faecal Myeloperoxidase as a Biomarker of Endoscopic Activity in Inflammatory Bowel Disease

A. Swaminathan, G. M. Borichevsky, T. S. Edwards, E. Hirschfeld, T. C. Mules, C. M. Frampton, A. S. Day, M. B. Hampton, A. J. Kettle, R. B. Gearry

Summary: This study investigated the use of faecal myeloperoxidase (fMPO) as a biomarker for the activity of inflammatory bowel disease (IBD). The results showed that fMPO was significantly correlated with endoscopic activity and could accurately predict the severity and complexity of the disease.

JOURNAL OF CROHNS & COLITIS (2022)

Review Immunology

Inside the phagosome: A bacterial perspective

Mark B. Hampton, Nina Dickerhof

Summary: The neutrophil phagosome poses a challenging environment for bacteria, but our understanding of the complex biochemistry within it is incomplete. Heterogeneity among phagosomes suggests that investigating the conditions that allow bacteria to survive could lead to new therapeutic strategies. Monitoring or recovering bacteria from phagosomes and unbiased screening for essential bacterial genes are important for gaining insights into their survival mechanisms inside neutrophil phagosomes.

IMMUNOLOGICAL REVIEWS (2023)

Article Chemistry, Physical

Synthesis and Characterization of a Cannabinoid Type 2 Receptor Photoactivated Prodrug

Jiazhen Yin, Raahul Sharma, Joel D. A. Tyndall, Natasha L. Grimsey, Andrea J. Vernall

Summary: GPCR ligand prodrugs that can be released on demand have important applications in studying the consequences of GPCR activation or blockade. The development and characterization of a cannabinoid type 2 receptor agonist prodrug based on a photo caging moiety is described here. The prodrug showed rapid photolysis and good stability, but had significantly decreased binding affinity to the human cannabinoid type 2 receptor compared to the active parent ligand.

CHEMPHOTOCHEM (2023)

Article Biochemistry & Molecular Biology

MerA functions as a hypothiocyanous acid reductase and defense mechanism in Staphylococcus aureus

Heather L. Shearer, Vu V. Loi, Paul Weiland, Gert Bange, Florian Altegoer, Mark B. Hampton, Haike Antelmann, Nina Dickerhof

Summary: A study reveals that Staphylococcus aureus has developed a defense mechanism against the antimicrobial oxidant hypothiocyanous acid (HOSCN) in order to cause infections in humans. The enzyme MerA acts as a HOSCN reductase, protecting the bacteria from oxidative stress. Understanding the structure and function of MerA may lead to new strategies for treating S. aureus infections.

MOLECULAR MICROBIOLOGY (2023)

Article Hematology

Plasminogen Receptors Promote Lipoprotein(a) Uptake by Enhancing Surface Binding and Facilitating Macropinocytosis

Halima Siddiqui, Nikita Deo, Malcolm T. Rutledge, Michael J. A. Williams, Gregory M. I. Redpath, Sally P. A. Mccormick

Summary: This study identifies multiple plasminogen receptors involved in the endocytosis of Lp(a), which enhance surface binding and stimulate macropinocytosis of Lp(a). While the findings were obtained in cell culture models with limitations, they could have clinical relevance due to the availability of drugs that inhibit macropinocytosis for cancer therapy and antidepressant compounds.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2023)

Article Microbiology

Identification of Streptococcus pneumoniae genes associated with hypothiocyanous acid tolerance through genome-wide screening

Heather L. Shearer, Paul E. Pace, Leah M. Smith, Peter C. Fineran, Allison J. Matthews, Andrew Camilli, Nina Dickerhof, Mark B. Hampton

Summary: By using saturation transposon mutagenesis and deep sequencing, this study identified 37 genes associated with hypothiocyanous acid (HOSCN) tolerance in Streptococcus pneumoniae. These genes are involved in metabolism, membrane transport, DNA repair, and oxidant detoxification. Validation experiments showed that most of the single-gene deletion mutants exhibited increased sensitivity to HOSCN, and some mutants showed enhanced activity of antioxidant defense systems. The double deletion of glutathione reductase and sodA significantly sensitized the bacteria. The HOSCN defense systems identified in this study may serve as viable targets for novel therapeutics against S. pneumoniae.

JOURNAL OF BACTERIOLOGY (2023)

Article Chemistry, Medicinal

Highly potent dual-targeting angiotensin-converting enzyme 2 (ACE2) and Neuropilin-1 (NRP1) peptides: A promising broad-spectrum therapeutic strategy against SARS-CoV-2 infection

Shuang Mei, Su Jiang, Yuting Wang, Han Jing, Peng Yang, Miao-Miao Niu, Jindong Li, Kai Yuan, Yan Zhang

Summary: This study identifies a dual-targeting peptide, AP-1, that effectively inhibits variants of concern (VOCs) of SARS-CoV-2 without impairing host cell viability. The findings suggest that AP-1 could be a promising broad-spectrum agent for treating emerging VOCs of SARS-CoV-2.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Discovery of proteolysis-targeting chimera targeting undruggable proteins using a covalent ligand screening approach

Hyeonjun Lee, Ju Yeon Lee, Hyunsoo Jang, Hye Young Cho, Minhee Kang, Sang Hyun Bae, Suin Kim, Eunji Kim, Jaebong Jang, Jin Young Kim, Young Ho Jeon

Summary: By using liquid chromatography-tandem mass spectrometry and nuclear magnetic resonance experiments, we identified new chemical moieties that bind to the target sites of the protein of interest, allowing for reversible binding and protein degradation. This method has the potential to expand the application of PROTAC technology.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

A pro-death autophagy-based nanoplatform for enhancing antitumour efficacy with improved immune responses

Yingying Li, Xiyou Du, Xinru Kong, Yuelin Fang, Zhijing He, Dongzhu Liu, Hang Wu, Jianbo Ji, Xiaoye Yang, Lei Ye, Guangxi Zhai

Summary: This study proposes a novel nanoplatform based on the autophagy cascade to overcome the obstacles in chemo-immunotherapy. The platform combines chemotherapy and starvation therapy to initiate pro-death autophagy and enhance antigen presentation, while also remodeling the immunosuppressive tumor microenvironment. Furthermore, the study discovers a new therapeutic direction for the respiration inhibitor 3-bromopyruvic acid (3BP) in cancer treatment. Overall, this study offers an opportunity to improve antitumor efficacy and boost immune responses.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

A novel scaffold long-acting selective estrogen receptor antagonist and degrader with superior preclinical profile against ER plus breast cancer

Bingsi Wang, Mingxu Ma, Yusen Dai, Pengfei Yu, Liang Ye, Wenyan Wang, Chunjie Sha, Huijie Yang, Yingjie Yang, Yunjing Zhu, Lin Dong, Shujuan Wei, Linlin Wang, Jingwei Tian, Hongbo Wang

Summary: Breast cancer is a common malignant tumor in women, and drug resistance remains a clinical challenge. In this study, a novel compound, G-5b, was developed with potent antagonistic and degradation activities comparable to the current drug fulvestrant. G-5b also showed improved stability and solubility. Mechanistically, G-5b engages the proteasome pathway to degrade ER, inhibiting the ER signaling pathway and inducing apoptosis and cell cycle arrest. In animal models, G-5b exhibited superior pharmacokinetics and pharmacodynamics properties. Overall, G-5b is a promising long-acting SERD worthy of further investigation and optimization.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

HDAC specificity and kinase off-targeting by purine-benzohydroxamate anti-hematological tumor agents

Karoline B. Waitman, Larissa C. de Almeida, Marina C. Primi, Jorge A. E. G. Carlos, Claudia Ruiz, Thales Kronenberger, Stefan Laufer, Marcia Ines Goettert, Antti Poso, Sandra V. Vassiliades, Vinicius A. M. de Souza, Monica F. Z. J. Toledo, Neuza M. A. Hassimotto, Michael D. Cameron, Thomas D. Bannister, Leticia Costa-Lotufo, Joa o A. Machado-Neto, Mauricio T. Tavares, Roberto Parise-Filho

Summary: A series of hybrid inhibitors combining pharmacophores of known kinase inhibitors and benzohydroxamate HDAC inhibitors were synthesized and evaluated for their anticancer activity and pharmacokinetic properties. Compounds 4d-f exhibited promising cytotoxicity against hematological cells and moderate activity against solid tumor models. Compound 4d showed potent inhibition of multiple kinase targets and had stable interactions with HDAC and members of the JAK family. These compounds showed selective cytotoxicity with minimal effects on non-tumorigenic cells and favorable pharmacokinetic profiles.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Unexpected rearrangement of ivermectin in the synthesis of new derivatives with trypanocidal and antiplasmodial activities

Michal Sulik, Diana Fontinha, Dietmar Steverding, Szymon Sobczak, Michal Antoszczak, Miguel Prudencio, Adam Huczynski

Summary: This study describes the synthesis of the first-in-class ivermectin derivatives obtained through derivatization of the C13 position, along with the unexpected rearrangement of the macrolide ring. These derivatives show potential for antiparasitic activity and are important for the development of new antiparasitic agents.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Novel ligustilide derivatives target quorum sensing system LasR/LasB and relieve inflammatory response against Pseudomonas aeruginosa infection

Jun Liu, Qiu-Xian Chen, Wen-Fu Wu, Dong Wang, Si -Yu Zhao, Jia-Hao Li, Yi-Qun Chang, Shao-Gao Zeng, Jia-Yi Hu, Yu-Jie Li, Jia-Xin Du, Shu-Meng Jiao, Hai-Chuan Xiao, Qiang Zhang, Jun Xu, Jian-Fu Zhao, Hai -Bo Zhou, Yong-Heng Wang, Jian Zou, Ping-Hua Sun

Summary: A new anti-infective drug strategy has been discovered to attenuate virulence and modulate inflammation caused by drug-resistant Pseudomonas aeruginosa infections. Compound 5f inhibits biofilm formation, macrophage migration, and inflammatory response induced by P. aeruginosa, showing potential as a novel candidate against drug-resistant infections.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Design and synthesis of pterostilbene derivatives bearing triazole moiety that might treat DSS-induced colitis in mice through modulation of NF-KB/ MAPK signaling pathways

Liuzeng Chen, Ke Wang, Lingyun Wang, Wei Wang, Lifan Wang, Jia Li, Xiaohan Liu, Mengya Wang, Banfeng Ruan

Summary: In this study, a series of novel anti-inflammatory compounds were designed and synthesized based on the natural product pterostilbene skeleton. Among them, compound 8 showed the highest activity and exhibited its effects through inhibition of pro-inflammatory cytokines by blocking the NF-KB/MAPK signaling pathway. Compound 8 also demonstrated a good relieving effect on acute colitis in mice and showed good safety in acute toxicity experiments.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Discovery of 4-(N-dithiobenzyl piperazine)-1,8-naphthalimide as a potent multi-target antitumor agent with good efficacy, limited toxicity, and low resistance

Si-Min Liang, Gui-Bin Liang, Hui-Ling Wang, Hong Jiang, Xian-Li Ma, Jian-Hua Wei, Ri-Zhen Huang, Ye Zhang

Summary: A series of novel multi-target antitumor agents were designed, synthesized, and evaluated. Some compounds exhibited significant antitumor activity and one compound showed excellent efficacy, limited toxicity, and low resistance. Further mechanism studies revealed that the compound exerted antitumor effects through multiple pathways.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)